Evofem Biosciences (EVFM) Notes Payables (2018 - 2026)
Evofem Biosciences (EVFM) recorded Notes Payables of $362,000 in Q2 2026, down 5.5% from $383,000 a year earlier and down 98.9% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Notes Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, Evofem Biosciences reported Notes Payables of $147,000, up 8.9% from FY2024.
- Annual Notes Payables has a five-year compound annual growth rate of -69.1% (FY2020 to FY2025).
- Across earlier years, Notes Payables came in at $135,000 in FY2024 (-99.1%), $14.73 million in FY2023 (-62.6%) and $39.42 million in FY2022.
- Quarterly Notes Payables has ranged from $135,000 in Q4 2024 to $129.33 million in Q3 2022 over the past five years.
- On a year-over-year basis, Notes Payables rose in three of the last eight quarters, with an average decline of 28.1%.
- Peak year-over-year performance for Notes Payables in the last five years was growth of 284.8% in Q2 2023, against a decline of 99.5% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $33.4 million (Q1 2026), $147,000 (Q4 2025) and $291,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 362,000.00 |
| Mar 31, 2026 | 33.40 Mn |
| Dec 31, 2025 | 147,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 31.35 Mn |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 397,000.00 |
| Mar 31, 2024 | 54.65 Mn |
| Dec 31, 2023 | 14.73 Mn |
| Sep 30, 2023 | 13.11 Mn |
| Jun 30, 2023 | 15.60 Mn |
| Mar 31, 2023 | 23.81 Mn |
| Dec 31, 2022 | 39.42 Mn |
| Sep 30, 2022 | 129.33 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 267,000.00 |
| Sep 30, 2021 | 68.72 Mn |
| Jun 30, 2021 | 44.31 Mn |
API Access
Evofem Biosciences Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();